TGF‐βRII / EP300 /SMAD4 cascade signaling pathway promotes invasion and glycolysis in oral squamous cell carcinoma
Journal of Oral Pathology & Medicine · 2023
DOI: 10.1111/jop.13424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2023. Verfasst von Dandan Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Preresearch Project of the 2019 National Natural(Social)Science Foundation of North Sichuan Medical College, The First Batch of Clinical Research Project of the Affiliated Hospital of North Sichuan Medical College, Special fund for municipal schools.
Abstract (Originalsprache)
Introduction
EP300 is considered to be a cancer suppressor gene that plays a role in tumor development, but some studies have reported that it is not an oral squamous cell carcinoma suppressor gene, because there was neither epigenetic inactivation of the gene nor a mutation resulting in functional impairment. However, there is no relevant study on whether EP300 is the exact carcinogenic effect and its mechanisms of carcinogenic effects in oral squamous cell carcinoma.
Methods
Western blot analysis and quantitative real time polymerase chain reaction experiments verified the protein and mRNA expression of EP300 in oral squamous cell carcinoma; The effects of EP300 knockout on glucose consumption and lactic acid production were detected by glycolysis experiments; The relationship between pathway‐related proteins and EP300 was verified by bioinformatics analysis and co‐immunoprecipitation experiment.
Results
Our experimental results confirm that the protein and mRNA of EP300 are highly expressed in oral squamous cell carcinoma, and after knocking out the EP300, the glycolysis ability, invasion, migration, and other biological functions of oral squamous cell carcinoma, are inhibited at the same time. Pathway‐related experiments have confirmed that EP300 plays a role in promoting cancer through the transforming growth factor‐beta receptor II (TGF‐βRII)/EP300/Smad4 cascade pathway.
Conclusion
EP300 plays a carcinogenic role in OSCC showed that the TGF‐βRII/EP300/Smad4 cascade pathway is involved in oral squamous cell carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
- Department of Stomatology, North Sichuan Medical College, Nanchong, China.
ORCID-Profile: Ying Liu
Förderung
- Preresearch Project of the 2019 National Natural(Social)Science Foundation of North Sichuan Medical College
- The First Batch of Clinical Research Project of the Affiliated Hospital of North Sichuan Medical College
- Special fund for municipal schools
Zitieren
APA
Zhang, D., Peng, Y., Lin, G., Xiao, Q., Liu, H., Nan, X., Han, J., Zhao, R., Wang, Y., Liu, J., & Liu, Y. (2023). TGF‐βRII / EP300 /SMAD4 cascade signaling pathway promotes invasion and glycolysis in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.13424
Vancouver
Zhang D, Peng Y, Lin G, Xiao Q, Liu H, Nan X, et al. TGF‐βRII / EP300 /SMAD4 cascade signaling pathway promotes invasion and glycolysis in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine. 2023. doi:10.1111/jop.13424
BibTeX
@article{Zhang2023,
author = {Zhang, Dandan and Peng, Yanshuang and Lin, Gaoren and Xiao, Qian and Liu, Han and Nan, Xiaoxu and Han, Jinpeng and Zhao, Runzhe and Wang, Yuzhu and Liu, Jialin and Liu, Ying},
title = {TGF‐βRII / EP300 /SMAD4 cascade signaling pathway promotes invasion and glycolysis in oral squamous cell carcinoma},
journal = {Journal of Oral Pathology & Medicine},
year = {2023},
doi = {10.1111/jop.13424}
}
EUVIMED